Publicité
English Flag
Biotech Finances - L'information stratégique des biodécideurs et des bioinvestisseurs
RECHERCHER SUR LE SITE
ET DANS LES ARCHIVES
samedi 18 mai 2013
 Mémoriser  
 
 

Communiqué de Presse

Source : PR NewsWire

DNA Sequencing: Emerging Technologies and Applications

Le 30/05/2012





NEW YORK, May 30, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:


DNA Sequencing: Emerging Technologies and Applications


http://www.reportlinker.com/p0254559/DNA-Sequencing-Emerging-Technologies-and-Applications.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics


INTRODUCTION


STUDY OBJECTIVES


BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for industrial enzymes. The key objective is to present a comprehensive analysis of the current market and its future direction in the enzymes market as an important tool for increasing the efficiency and specificity of the products in which the enzymes are used.


This report is an update to the previous report on industrial enzymes and explores the present and future strategies within the industrial enzymes market, which includes the detergent, technical, food and beverages, and animal feed sectors. The improvisation of the market, the setbacks and the needs of the market are discussed in this report. The comparisons, usage, and the advantages and disadvantages of types of enzymes are also portrayed in this report.


A detailed analysis of the enzymes industry structure has been conducted. Revenues are broken down by region. Sales figures are estimated for the five-year period from 2011 through 2016.


Applications for industrial enzymes are also discussed separately in the report, with emphasis of the use in technical enzymes and the food and beverages enzymes. The report also covers significant patents and their allotments in each category.


REASONS FOR DOING THIS STUDY


With an increase in the use of enzymes, enzyme usage is completely justifiable because they are natural and biodegradable. By using biodegradable enzymes as substitutes in the place of chemical-based products, the manufacturing process is being redeveloped into a more environmentally friendly process, with less corrosive conditions. Enzyme compatibility with the environment in addition to their ability to increase process efficiency and provide product specificity has enhanced the enzymes market globally.


R&D spending, along with increasing competition, patent expiries and new technologies, are directing this in a new direction. The industry took a leap in 2010 with new advancements and the need for cost reductions. This study looks at almost all the systems affected by various factors.


Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type/ technology in light of new technologies, growing competition and changing customer needs.


INTENDED AUDIENCE


This study contributes to the areas of market growth in food and beverages, animal feed, detergents, leather, and other technical enzyme manufacturers and users. Chemical, biochemical and biotechnical companies and industries, and research institutes will find this study to be of interest.


SCOPE OF THE STUDY


The scope of this study encompasses the industrial enzymes, bio-technical, chemical and biotechnology markets. BCC analyzes each market and its applications, regulatory environment, technology involved, market projections and market share. Technological issues include the latest trends and developments.


METHODOLOGY


BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various chemical, biotechnical, food and beverages, and technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.


INFORMATION SOURCES


Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of enzymes in the chemical, biotechnology, food and beverages, leather, and detergent industries. Data were gathered from various industry sources. BCC spoke with officials within the industry, consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.


ABOUT THE AUTHOR


The study has been carried out by a team of professionals in the biotechnology industry. The project manager for this project is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has over 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents for Chromatography; Spectroscopy, An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets.


TABLE OF CONTENTS


CHAPTER ONE: INTRODUCTION 1


STUDY GOALS AND OBJECTIVES 1


REASONS FOR DOING THE STUDY 1


INTENDED AUDIENCE 2


SCOPE AND FORMAT 3


METHODOLOGY 3


INFORMATION SOURCES 4


RELATED BCC REPORTS 4


ANALYST CREDENTIALS 4


BCC ON-LINE SERVICES 4


DISCLAIMER 5


CHAPTER TWO: EXECUTIVE SUMMARY 6


SUMMARY TABLE GLOBAL VALUE OF SEQUENCING PRODUCTS


AND SERVICES BY TYPE, THROUGH 2016 ($ MILLIONS) 6


SUMMARY FIGURE GLOBAL VALUE OF SEQUENCING PRODUCTS


AND SERVICES BY TYPE, 2010-2016 ($ MILLIONS) 7


EXECUTIVE SUMMARY (CONTINUED) 8


CHAPTER THREE: OVERVIEW 9


INTRODUCTION 9


TABLE 1 SCOPE OF THIS REPORT 9


SEQUENCING INDUSTRY MARKET 10


TABLE 2 GLOBAL VALUE OF THE SEQUENCING MARKET BY


PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 10


SEQUENCING INDUSTRY GROWTH DRIVING FORCES 11


TABLE 3 KEY GROWTH DRIVING FORCES IN THE DNA


SEQUENCING MARKET 11


SEQUENCING PRODUCTS 12


SEQUENCING INSTRUMENTS AND CONSUMABLES 12


SAMPLE PREPARATION REAGENTS AND KITS 13


BIOINFORMATICS 13


SEQUENCING SERVICES 13


SEQUENCING PRODUCT LIFE CYCLE STATUS 14


TABLE 4 LIFE CYCLE OF DNA SEQUENCING TECHNOLOGIES 14


SEQUENCING INDUSTRY 15


TABLE 5 SEQUENCING INSTRUMENT COMPETITORS BY


TECHNOLOGY 15


TABLE 5 (CONTINUED) 16


CHAPTER FOUR: DNA SEQUENCING TECHNOLOGY 17


INTRODUCTION 17


FIGURE 1 CENTRAL MOLECULAR BIOLOGY DOGMA 17


GENOMIC VARIATION 18


TABLE 6 TYPES OF HUMAN GENOME VARIATIONS 18


FIGURE 2 DNA, MRNA, AND GENETIC VARIATION 19


DNA SEQUENCING ANALYSIS 20


TABLE 7 DNA SEQUENCING METHODS 21


HISTORY OF DNA SEQUENCING 21


TABLE 8 DNA SEQUENCING HISTORICAL TIMELINE 21


TABLE 8 (CONTINUED) 22


HISTORY OF DNA SEQUENCING (CONTINUED) 23


HISTORY OF DNA SEQUENCING (CONTINUED) 24


HISTORY OF DNA SEQUENCING (CONTINUED) 25


HISTORY OF DNA SEQUENCING (CONTINUED) 26


FIGURE 3 SEQUENCING COST TREND, BASE PAIRS SEQUENCED


PER DOLLAR 27


FIGURE 4 SEQUENCING INSTRUMENT THROUGHPUT TREND,


BASE PAIRS PER DAY 28


FIGURE 5 HUMAN GENOME SEQUENCING COST TREND 29


FIGURE 6 $1,000 GENOME PRODUCT SPACE 30


DNA SEQUENCING WORKFLOW 31


TABLE 9 DNA SEQUENCING WORKFLOW 31


TARGETING TECHNOLOGIES 32


TABLE 10 CHEMICAL TARGETING TECHNOLOGIES 33


DNA SEQUENCING TECHNOLOGIES 34


TABLE 11 DNA SEQUENCING TECHNOLOGIES 34


NEXT-GENERATION SEQUENCING TECHNOLOGIES 35


TABLE 12 NEXT-GENERATION SEQUENCING TECHNOLOGIES 35


Reversible Termination (Illumina Genome Analyzer and


HiSeq) 35


Pyrosequencing (Roche-454) 36


Sequencing by Ligation (Life Technologies) 37


EMERGING SEQUENCING TECHNOLOGIES 37


TABLE 13 EMERGING SEQUENCING TECHNOLOGIES 38


BENCHTOP SEQUENCERS 39


TABLE 14 BENCHTOP SEQUENCING TECHNOLOGIES 39


SEQUENCING INSTRUMENT PERFORMANCE METRICS 40


TABLE 15 SEQUENCING PLATFORM THROUGHPUT


PERFORMANCE 40


TABLE 16 SEQUENCING PLATFORM ACCURACY PERFORMANCE 41


TABLE 17 SEQUENCING INSTRUMENT COST 42


SEQUENCING INSTRUMENT SUMMARY 42


TABLE 18 SEQUENCING INSTRUMENT SUMMARY 43


BIOINFORMATICS TECHNOLOGIES 44


TABLE 19 NGS SEQUENCING BIOINFORMATICS WORKFLOW 44


Base Calling 45


Mapping to a Reference Sequence 46


TABLE 20 SEQUENCE ANNOTATION TYPES 47


Variant Analysis 47


SEQUENCING PRODUCT LIFE CYCLE 48


TABLE 21 LIFE CYCLE OF DNA SEQUENCING TECHNOLOGIES 49


SEQUENCING INSTRUMENT CUMULATIVE INSTALLED BASE 49


FIGURE 7 GLOBAL CUMULATIVE INSTALLED BASE OF DNA


SEQUENCERS, THROUGH JANUARY 2012 50


CHAPTER FIVE: DNA SEQUENCING APPLICATIONS 51


INTRODUCTION 51


FIGURE 8 WHOLE-GENOME SEQUENCING PROJECTS FOR


PROKARYOTES AND EUKARYOTES, APRIL 2010 AND DECEMBER


2011 51


FIGURE 8 (CONTINUED) 52


GENETIC ANALYSIS 53


TABLE 22 GENETIC ANALYSIS FORMATS COMPARISON 54


TABLE 23 SEQUENCING ANALYSIS APPLICATIONS 55


TABLE 23 (CONTINUED) 56


TABLE 24 DE NOVO VERSUS RESEQUENCING REQUIREMENTS 56


DE NOVO WHOLE GENOME SEQUENCING 57


TABLE 25 ESTIMATED NUMBER OF SPECIES ON EARTH AND


PERCENTAGE SEQUENCED, DECEMBER 2011 58


RESEQUENCING 59


Whole-Genome Resequencing 59


FIGURE 9 DISEASE-CAUSING ALLELES AT MAF5 AND MAF1 60


TABLE 26 SINGLE SEQUENCER: WHOLE-GENOME THROUGHPUT


TRENDS, 1975-2011 61


Targeted Resequencing 62


SEQ-BASED METHODS 63


TABLE 27 GENETIC ANALYSIS APPLICATIONS IN WHICH


SEQUENCING COMPETES WITH MICROARRAYS 63


ChIPSeq 64


TABLE 28 COMPARISON OF SEQUENCING WITH MICROARRAYS


FOR CHIP APPLICATIONS 64


DNase-Seq 65


Gene Expression Analysis 65


TABLE 29 COMPARISON OF SEQUENCING AND MICROARRAYS


FOR GENE EXPRESSION ANALYSIS 65


Gene Expression ... (Continued) 66


MethylSeq 67


STRUCTURAL VARIATION STUDIES 67


COMPLEMENTARY SEQUENCING AND MICROARRAY


PLATFORMS 68


SEQUENCING END-USE APPLICATIONS 69


RESEARCH, DRUG DISCOVERY AND DEVELOPMENT 69


Research, Drug Discovery ... (Continued) 70


TABLE 30 PHARMACEUTICAL/DIAGNOSTICS SEQUENCING


PARTNERS 71


Research, Drug Discovery ... (Continued) 72


CLINICAL SEQUENCING 73


TABLE 31 SEQUENCING APPLICATIONS IN CLINICAL


DIAGNOSTICS 73


Clinical Sequencing (Continued) 74


Clinical Sequencing (Continued) 75


TABLE 32 HPV DIAGNOSTICS COMPETITORS 76


CONSUMER SEQUENCING 77


FIGURE 10 GENETIC ANALYSIS COST AND INFORMATION


CONTENT TRENDS (BP/$) 78


Consumer Sequencing (Continued) 79


AGRICULTURAL SEQUENCING 80


TABLE 33 SEQUENCING IMPACT ON AGRICULTURAL PRODUCT


CLASSES 80


MICROBIAL SEQUENCING 81


TABLE 34 KEY APPLICATIONS IN MICROBIAL SEQUENCING 82


FORENSICS SEQUENCING 83


TABLE 35 KEY APPLICATIONS IN FORENSICS AND HUMAN


IDENTITY SEQUENCING 83


CHAPTER SIX: DNA SEQUENCING INITIATIVES 84


FIGURE 11 NIH FUNDING AWARDS FOR DNA SEQUENCINGRELATED


BY INSTITUTE, 2010-2011 85


FIGURE 11 (CONTINUED) 86


FIGURE 12 NIH FUNDING FOR DNA SEQUENCING-RELATED


PROJECTS, 2000-2001 AND 2010-2011 87


NHGRI $1,000 GENOME PROJECT FUNDING 87


TABLE 36 NHGRI GRANTS UNDER THE $1,000 GENOME PROGRAM,


FISCAL YEAR 2009-2011 ($ MILLIONS) 88


SEQUENCING-RELATED GENOMICS PROJECTS 89


TABLE 37 IMPORTANT SEQUENCING RESEARCH INITIATIVES 89


TABLE 37 (CONTINUED) 90


TABLE 37 (CONTINUED) 91


GENOME SEQUENCING PROJECTS 92


Personal Genome Project 92


Archon X Prize in Genomics 92


Genomes 10K Project 93


1,000 Plant and Animal Reference Project 93


MEDICAL SEQUENCING PROJECTS 94


Exome Sequencing of Mendelian Disorders 94


Allelic Spectrum in Common Disease Program 95


Clinseq Project 95


CANCER SEQUENCING PROJECTS 95


International Cancer Genome Consortium 96


Cancer Genome Atlas 96


Tumor Sequencing Project 97


Cancer Genome Project 97


Genomics of Drug Sensitivity in Cancer 98


Catalogue of Somatic Mutations in Cancer 98


Genomics Initiative 99


MICROBIAL SEQUENCING PROJECTS 99


Human Microbiome Project 99


Microbial Genome Sequencing Project 100


Marine Microbial Genome Sequencing Project 100


Fungal Genome Initiative 101


Pathogen Sequencing Program 101


Genomic Encyclopedia of Bacteria and Archaea 101


Metagenomics of the Human Intestinal Tract 102


10,000 Microbial Genomes Project 103


Earth Microbiome Project 103


GENOME VARIATION PROJECTS 103


Encyclopedia of DNA Elements 103


Genomics of Gene Regulation Project 104


1,000 Genomes Project 104


1,000 Plant and Animal Genomes Project 105


Yanhuang Project 105


AGRICULTURAL GENOMICS PROJECTS 106


National Plant Genome Initiative 106


Africa Orphan Crops Consortium 106


IMPACT OF SEQUENCING PROJECTS 106


FIGURE 13 GROWTH IN BASE PAIRS DEPOSITED IN GENBANK,


1988-2011 (BILLIONS) 107


CHAPTER SEVEN: DNA SEQUENCING INDUSTRY STRUCTURE 108


OVERVIEW 108


TABLE 38 DNA SEQUENCING INDUSTRY TRANSITION 108


TABLE 39 DNA SEQUENCING INDUSTRY TRANSITION 109


INDUSTRY STRUCTURE ANALYSIS 109


FIGURE 14 DNA SEQUENCING INDUSTRY STRUCTURE, 1995-2005 110


INDUSTRY STRUCTURE ANALYSIS (CONTINUED) 111


FIGURE 15 DNA SEQUENCING INDUSTRY STRUCTURE, POST-2005 112


SEQUENCING INSTRUMENT AND CONSUMABLES INDUSTRY 113


SEQUENCING INSTRUMENT INDUSTRY 113


TABLE 40 SEQUENCING INSTRUMENT COMPETITORS BY


TECHNOLOGY 114


Sequencing Instrument ... (Continued) 115


NGS INSTRUMENT COMPETITOR MARKET SHARES 116


FIGURE 16 NGS INSTRUMENT COMPETITOR MARKET SHARE, 2011


(%) 116


FIGURE 16 (CONTINUED) 117


FIGURE 17 NGS HIGH-THROUGHPUT INSTRUMENT COMPETITOR


MARKET SHARE, 2011 (%) 118


FIGURE 18 NGS BENCHTOP INSTRUMENT COMPETITOR MARKET


SHARE, 2011 (%) 119


EMERGING SEQUENCING INDUSTRY 120


TABLE 41 EMERGING SEQUENCING INDUSTRY 120


TABLE 42 NANOPORE SEQUENCING INDUSTRY 121


TABLE 43 POTENTIAL BENEFITS OF NANOPORE SEQUENCING 122


DNA SEQUENCING END USERS 122


TABLE 44 DNA SEQUENCING END-USER MARKET SEGMENTS 123


Major Sequencing Centers 123


TABLE 45 TOP 10 NGS INSTRUMENT INSTALLATIONS BY MAJOR


SEQUENCING CENTER, DECEMBER 2011 124


FIGURE 19 MAJOR SEQUENCING CENTER'S SHARE OF THE


GENOME SEQUENCING PROJECTS MARKET BY NUMBER OF


SEQUENCING PROJECTS, DECEMBER 2011 (%) 125


FIGURE 20 BGI ADOPTION OF NEXT-GENERATION SEQUENCERS,


2008 AND 2011 126


FIGURE 20 (CONTINUED) 127


Large-Core Sequencing Centers 127


TABLE 46 LARGE-CORE SEQUENCING CENTERS 128


Small to Mid-Size Laboratories 129


Sequencing Service Laboratories 129


EARLY ADAPTORS 130


SEQUENCING SAMPLE PREPARATION INDUSTRY 130


SEQUENCE CAPTURE INDUSTRY 131


TABLE 47 POSITIONING OF SEQUENCE CAPTURE FORMATS 131


SAMPLE PREP COMPETITORS 132


TABLE 48 SEQUENCING SAMPLE PREPARATION COMPANY


POSITIONING 133


Sample Prep Competitors (Continued) 134


Sample Prep Competitors (Continued) 135


TABLE 49 PREPARATION FORMATS 136


DIGITAL PCR INDUSTRY 136


TABLE 50 DIGITAL PCR INDUSTRY 137


Digital PCR Industry (Continued) 138


BIOINFORMATICS INDUSTRY 139


TABLE 51 DNA SEQUENCING BIOINFORMATICS COMPANY


POSITIONING 140


PHYSICAL MAPPING 141


TABLE 52 PHYSICAL MAPPING INDUSTRY 142


SEQUENCING SERVICES INDUSTRY 142


TABLE 53 DNA SEQUENCING SERVICES COMPANIES AND


INSTITUTIONS POSITIONING BY MARKET FOCUS 143


CLINICAL SEQUENCING INDUSTRY 144


TABLE 54 LABORATORIES OFFERING NGS CLINICAL


SEQUENCING SERVICES 145


Clinical Sequencing Industry (Continued) 146


Clinical Sequencing Industry (Continued) 147


CONSUMER SEQUENCING INDUSTRY 148


TABLE 55 MEDIUM- TO HIGH-CONTENT CONSUMER GENOMICS


COMPANIES 148


TABLE 55 (CONTINUED) 149


FIGURE 21 PERSONAL GENOMICS COMPETITIVE SPACE BY TEST


COST AND SCOPE 150


TABLE 56 CONSUMER GENOMICS COMPETITOR STRATEGIES ($) 151


AGRICULTURAL GENOMICS INDUSTRY 152


TABLE 57 KEY COMPETITORS IN THE AGRICULTURAL SEED


MARKET 152


AGRICULTURAL GENOMICS INDUSTRY (CONTINUED) 153


SEQUENCING INDUSTRY ACQUISITIONS AND STRATEGIC


ALLIANCES 154


ACQUISITIONS 154


TABLE 58 SEQUENCING INDUSTRY ACQUISITIONS, 2009-2011 154


TABLE 58 (CONTINUED) 155


STRATEGIC ALLIANCES 156


TABLE 59 SEQUENCING INDUSTRY STRATEGIC ALLIANCES, 2009-


2011 157


TABLE 59 (CONTINUED) 158


TABLE 59 (CONTINUED) 159


TABLE 59 (CONTINUED) 160


CLINICAL SEQUENCING ALLIANCES 161


Sequencing Workflow Alliances 162


Sequencing ... (Continued) 163


Sequencing ... (Continued) 164


Emerging Sequencing Technology Alliances 165


Sequencing Market Expansion Alliances 166


Sequencing Market ... (Continued) 167


Sequencing Market ... (Continued) 168


CHAPTER EIGHT: DNA SEQUENCING MARKETS 169


GROWTH DRIVING FORCES 169


TABLE 60 DNA SEQUENCING KEY GROWTH DRIVING FORCES 169


GROWTH DRIVING FORCES (CONTINUED) 170


GROWTH DRIVING FORCES (CONTINUED) 171


SEQUENCING MARKET SUMMARY 172


TABLE 61 GLOBAL VALUE OF THE SEQUENCING MARKET BY


PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 172


SEQUENCING MARKET SUMMARY (CONTINUED) 173


SEQUENCING INSTRUMENTS AND CONSUMABLES MARKETS 174


TABLE 62 GLOBAL VALUE OF THE SEQUENCING INSTRUMENTS


AND CONSUMABLES MARKET BY PRODUCT TYPE, THROUGH


2016 ($ MILLIONS) 174


SEQUENCING INSTRUMENTS AND CONSUMABLES BY


PLATFORM 175


TABLE 63 GLOBAL VALUE OF SEQUENCING INSTRUMENTS BY


PLATFORM, THROUGH 2016 ($ MILLIONS) 175


Sequencing Instruments ...(Continued) 176


TABLE 64 GLOBAL VALUE OF THE SEQUENCING CONSUMABLES


MARKET BY PLATFORM, THROUGH 2016 ($ MILLIONS) 177


NGS INSTRUMENTS AND CONSUMABLES BY PLATFORM 178


TABLE 65 GLOBAL VALUE OF NGS INSTRUMENTS AND


CONSUMABLES BY PLATFORM, THROUGH 2016 ($ MILLIONS) 178


SEQUENCING INSTRUMENTS AND CONSUMABLES BY


END USER 179


TABLE 66 GLOBAL VALUE OF SEQUENCING INSTRUMENTS AND


CONSUMABLES BY CUSTOMER TYPE, THROUGH 2016 ($


MILLIONS) 179


Sequencing Instruments ... (Continued) 180


TABLE 67 GLOBAL VALUE OF SANGER SEQUENCING


INSTRUMENTS AND CONSUMABLES BY CUSTOMER TYPE,


THROUGH 2016 ($ MILLIONS) 181


TABLE 68 GLOBAL VALUE OF NGS SEQUENCING INSTRUMENTS


AND CONSUMABLES BY CUSTOMER TYPE, THROUGH 2016 ($


MILLIONS) 182


TABLE 69 GLOBAL VALUE OF EMERGING SEQUENCING


INSTRUMENTS AND CONSUMABLES BY CUSTOMER TYPE,


THROUGH 2016 ($ MILLIONS) 183


SEQUENCING SAMPLE PREP MARKETS 183


TABLE 70 GLOBAL VALUE OF THE SEQUENCING SAMPLE PREP


MARKET BY APPLICATION, THROUGH 2016 ($ MILLIONS) 184


SEQUENCING BIOINFORMATICS MARKET 185


TABLE 71 GLOBAL VALUE OF THE SEQUENCING


BIOINFORMATICS MARKET BY SOFTWARE FUNCTION,


THROUGH 2016 ($ MILLIONS) 185


SEQUENCING SERVICES MARKETS 186


SEQUENCING SERVICES BY END-USER MARKET 186


TABLE 72 GLOBAL VALUE OF SEQUENCING SERVICES BY ENDUSER


MARKET, THROUGH 2016 ($ MILLIONS) 186


R&D, Pharma and Biotech 187


Consumer Sequencing 188


SEQUENCING SERVICES MARKETS BY TYPE OF


ANALYSIS 189


TABLE 73 GLOBAL VALUE OF SEQUENCING SERVICES BY


ANALYSIS TYPE, THROUGH 2016 ($ MILLIONS) 189


SEQUENCING SERVICES MARKET BY SPECIES 190


TABLE 74 GLOBAL VALUE OF SEQUENCING SERVICES BY


GENOME TYP THROUGH 2016 ($ MILLIONS) 191


APPLIED SEQUENCING SERVICES MARKET 191


TABLE 75 GLOBAL VALUE OF THE APPLIED SEQUENCING


SERVICES MARKET BY APPLICATION, THROUGH 2016 ($


MILLIONS) 191


Applied Sequencing ... (Continued) 192


CLINICAL SEQUENCING SERVICES MARKET 193


Summary 193


TABLE 76 GLOBAL VALUE OF CLINICAL SEQUENCING SERVICES


BY INDICATION, THROUGH 2016 ($ MILLIONS) 194


TABLE 77 GLOBAL VALUE OF CLINICAL SEQUENCING TESTS BY


TECHNOLOGY, THROUGH 2016 ($ MILLIONS) 195


TABLE 78 CLINICAL DIAGNOSTICS PLATFORM COMPARISON 196


Summary (Continued) 197


TABLE 79 STABILIZING MARKET FACTORS FOR SANGER


CLINICAL SEQUENCING 198


Cancer 198


TABLE 80 GLOBAL VALUE OF CLINICAL CANCER SEQUENCING


SERVICES BY INDICATION, THROUGH 2016 ($ MILLIONS) 199


Infectious Diseases 199


TABLE 81 GLOBAL VALUE OF CLINICAL INFECTIOUS DISEASE


SEQUENCING SERVICES BY INDICATION, THROUGH 2016 ($


MILLIONS) 200


Genetic Diseases 201


TABLE 82 GLOBAL VALUE OF CLINICAL GENETIC DISEASE


SEQUENCING SERVICES BY TYPE, THROUGH 2016 ($ MILLIONS) 201


TABLE 83 PRENATAL DIAGNOSTICS TESTS 202


Genetic Diseases (Continued) 203


Immunology 204


TABLE 84 GLOBAL VALUE OF IMMUNOLOGY CLINICAL


SEQUENCING SERVICES BY TYPE, THROUGH 2016 ($ MILLIONS) 205


TABLE 85 HLA TESTING MARKET 206


SEQUENCING MARKETS BY REGION 207


SUMMARY 207


TABLE 86 GLOBAL VALUE OF THE DNA SEQUENCING MARKET BY


REGION, THROUGH 2016 ($ MILLIONS) 208


SEQUENCING INSTRUMENTS AND CONSUMABLES BY


REGION 209


TABLE 87 GLOBAL VALUE OF THE SEQUENCING INSTRUMENT


AND CONSUMABLES MARKET BY REGION, THROUGH 2016 ($


MILLIONS) 209


Sequencing Instruments ...(Continued) 210


TABLE 88 GLOBAL VALUE OF THE SEQUENCING SAMPLE PREP


MARKET BY REGION, THROUGH 2016 ($ MILLIONS) 211


SEQUENCING BIOINFORMATICS MARKET BY REGION 211


TABLE 89 GLOBAL VALUE OF THE SEQUENCING


BIOINFORMATICS MARKET BY REGION, THROUGH 2016 ($


MILLIONS) 212


SEQUENCING SERVICES MARKET BY REGION 212


TABLE 90 GLOBAL VALUE OF THE SEQUENCING SERVICES


MARKET BY REGION, THROUGH 2016 ($ MILLIONS) 212


U S SEQUENCING MARKET 213


TABLE 91 GLOBAL VALUE OF THE U S SEQUENCING MARKET BY


PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 213


GERMANY SEQUENCING MARKET 214


TABLE 92 GLOBAL VALUE OF THE GERMANY SEQUENCING


MARKET BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 214


U K SEQUENCING MARKET 215


TABLE 93 GLOBAL VALUE OF THE U K SEQUENCING MARKET BY


PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 215


CHINA SEQUENCING MARKET 216


TABLE 94 GLOBAL VALUE OF THE CHINA SEQUENCING MARKET


BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 216


JAPAN SEQUENCING MARKET 216


TABLE 95 GLOBAL VALUE OF THE JAPAN SEQUENCING MARKET


BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 217


CHAPTER NINE: SEQUENCING PATENTS 218


FIGURE 22 SEQUENCING PATENTS, 2001-2011 218


FIGURE 22 (CONTINUED) 219


FIGURE 23 SEQUENCING PATENTS BY REGION, 2001-2011 219


FIGURE 24 EMERGING SEQUENCING COMPANY PATENTS BY


REGION 220


FIGURE 24 (CONTINUED) 221


CHAPTER TEN: COMPANY PROFILES 222


23ANDME INC 222


ACCELRYS INC 223


ADAPTIVE TCR TECHNOLOGIES 223


AGILENT TECHNOLOGIES INC 224


ALTHEADX 225


AMBRY GENETICS 226


ASTRID BIOSCIENCE GMBH 226


ASURAGEN INC 227


AXEQ TECHNOLOGIES 228


BASE4INNOVATION LTD 228


BECKMAN COULTER 229


BGI 230


BGI (CONTINUED) 231


BIO LOGIS GMBH 232


BIOMATTERS LTD 232


BIONANO GENOMICS INC 233


BIOTIQUE SYSTEMS INC 233


BLUESEQ 234


TABLE 96 SEQUENCING MATCHING SERVICE PROVIDERS 235


CAERUS MOLECULAR DIAGNOSTICS 235


CARTAGENIA N V 235


COFACTOR GENOMICS 236


COMPLETE GENOMICS INC 236


CONEXIO GENOMICS 237


CORRELAGEN DIAGNOSTICS INC 238


CUSTOMARRAY INC 238


DANAHER 239


DECODEME 240


DNA ELECTRONICS LTD 241


DNANEXUS INC 241


DNASTAR INC 242


DNA VISION 243


ELECTRONIC BIOSCIENCES 243


ELECTRON OPTICA 244


EUROFINS MEDIGENOMIX GMBH 244


EUROFINS MWG OPERON 245


EXISTENCE GENETICS 246


EXPRESSION ANALYSIS INC 246


FASTERIS SA 247


FIREBIRD BIOMOLECULAR SCIENCES LLC 247


FLUIDIGM CORPORATION 248


FOUNDATION FOR APPLIED MOLECULAR EVOLUTION 249


FOUNDATION MEDICINE 249


GATC BIOTECH AG 250


GE HEALTHCARE 251


GENAPSYS 252


GENDX BV 252


GENEDATA AG 253


GENEDX INC 253


GENIA 254


TABLE 97 COMMERCIAL SEQUENCER COMPETITIVE


POSITIONING 255


GENOMATIX SOFTWARE GMBH 255


GENOMEQUEST INC 256


GENOMIC HEALTH INC 257


GENOVOXX GMBH 258


GEN-PROBE INC 259


GNUBIO INC 259


GOOD START GENETICS INC 260


HALCYON MOLECULAR 261


HALO GENOMICS AB 261


HELICOS BIOSCIENCES CORPORATION 262


INTERNATIONAL BUSINESS MACHINES CORP 263


ILLUMINA INC 264


TABLE 98 ILLUMINA SEQUENCING PORTFOLIO BY INSTRUMENT


($ PER YEAR) 264


INGENUITY SYSTEMS INC 265


INTEGENX 266


INTELLIGENT BIO-SYSTEMS INC 267


INTELLIGENT BIO-SYSTEMS INC (CONTINUED) 268


INTERNA GENOMICS BV 269


IP GENESIS INC 269


IREPERTOIRE 270


ISENTIO AS 271


KEYGENE N V 271


KNOME INC 272


LABORATORY FOR MOLECULAR MEDICINE 273


LASERGEN INC 274


LI-COR BIOSCIENCES 274


LIFECODEXX AG 275


LIFE TECHNOLOGIES INC 276


LINGVITAE HOLDING AS 277


LOCUS DEVELOPMENT INC 278


MACROGEN INC 278


MEDOMICS 279


MOOSBAUM GMBH 279


MYCROARRAY COM 280


NABSYS INC 280


NAVIGENICS INC 281


NETWORK BIOSYSTEMS 282


NEWGENE LTD 282


NOBLEGEN BIOSCIENCES 283


NOVOCRAFT TECHNOLOGIES INC 284


NUGEN TECHNOLOGIES INC 284


OMICIA INC 285


OPGEN INC 286


OXFORD GENE TECHNOLOGY 287


OXFORD NANOPORE TECHNOLOGIES 287


OXFORD NANOPORE ... (CONTINUED) 288


PACIFIC BIOSCIENCES 289


PATHOGENICA 290


PATHOGENETIX 291


PERKINELMER INC 291


PERKINELMER INC (CONTINUED) 292


PERSONALIS 293


POPULATION GENETICS TECHNOLOGIES LTD 293


POPULATION GENETICS ... (CONTINUED) 294


PROGNOSYS BIOSCIENCES INC 295


QIAGEN 296


QUANTALIFE INC 296


QUANTUMDX 297


RAINDANCE TECHNOLOGIES INC 297


TABLE 99 RAINDANCE STRATEGIC ALLIANCES 298


RAINDANCE TECHNOLOGIES INC (CONTINUED) 299


REAL TIME GENOMICS INC 300


ROCHE HOLDING AG 300


ROCHE HOLDING AG (CONTINUED) 301


RUBICON GENOMICS INC 302


SEQUENOM INC 303


SEQUENTA INC 304


SEQWRIGHT 305


SIEMENS AG 305


SLIPCHIP LLC 306


SMARTGENE SERVICES SARL 307


SOURCE BIOSCIENCE PLC 307


SORENSON GENOMICS 308


STRATOS GENOMICS INC 308


SUNDANCE DIAGNOSTICS INC 309


SISTEMAS GENOMICOS 309


THERAGEN ETEX CO LTD 310


TRANSGENOMIC INC 310


TROVAGENE INC 311


VERINATA HEALTH INC 312


WARP DRIVE BIO, LLC 312


X PRIZE FOUNDATION 313


ZS GENETICS 314


ZS GENETICS (CONTINUED) 315


REFERENCES 316


To order this report:


Genomics Industry: DNA Sequencing: Emerging Technologies and Applications


More Market Research Report


Check our Industry Analysis and Insights


__________________________


Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626




Reportlinker